# Sustained Release Lidocaine for Treatment of Scrotal Pain

> **NCT04026945** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 12 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT04026945
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-31
- **Primary completion:** 2021-03-24
- **Final completion:** 2021-03-24
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026945, "Sustained Release Lidocaine for Treatment of Scrotal Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04026945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*